223 related articles for article (PubMed ID: 29857058)
1. Screening method for trimethoprim/sulfamethoxazole-resistant small colony variants of Staphylococcus aureus.
Sato T; Kawamura M; Furukawa E; Fujimura S
J Glob Antimicrob Resist; 2018 Dec; 15():1-5. PubMed ID: 29857058
[TBL] [Abstract][Full Text] [Related]
2. Thymidine-Dependent Staphylococcus aureus Small-Colony Variants Are Induced by Trimethoprim-Sulfamethoxazole (SXT) and Have Increased Fitness during SXT Challenge.
Kriegeskorte A; Lorè NI; Bragonzi A; Riva C; Kelkenberg M; Becker K; Proctor RA; Peters G; Kahl BC
Antimicrob Agents Chemother; 2015 Dec; 59(12):7265-72. PubMed ID: 26369968
[TBL] [Abstract][Full Text] [Related]
3. Integrative omics analysis reveals insights into small colony variants of Staphylococcus aureus induced by sulfamethoxazole-trimethoprim.
Zhou J; He C; Yang H; Shu W; Liu Q
BMC Microbiol; 2024 Jun; 24(1):212. PubMed ID: 38877418
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic Detection of Hemin-Inducible Trimethoprim-Sulfamethoxazole Heteroresistance in Staphylococcus aureus.
Nurjadi D; Chanthalangsy Q; Zizmann E; Stuermer V; Moll M; Klein S; Boutin S; Heeg K; Zanger P
Microbiol Spectr; 2021 Oct; 9(2):e0151021. PubMed ID: 34704796
[TBL] [Abstract][Full Text] [Related]
5. In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus.
Chatterjee I; Kriegeskorte A; Fischer A; Deiwick S; Theimann N; Proctor RA; Peters G; Herrmann M; Kahl BC
J Bacteriol; 2008 Feb; 190(3):834-42. PubMed ID: 17905979
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and genetic diversity of Staphylococcus aureus small-colony variants in cystic fibrosis patients.
Yagci S; Hascelik G; Dogru D; Ozcelik U; Sener B
Clin Microbiol Infect; 2013 Jan; 19(1):77-84. PubMed ID: 22284387
[TBL] [Abstract][Full Text] [Related]
7. Optimized In Vitro Antibiotic Susceptibility Testing Method for Small-Colony Variant Staphylococcus aureus.
Precit MR; Wolter DJ; Griffith A; Emerson J; Burns JL; Hoffman LR
Antimicrob Agents Chemother; 2016 Jan; 60(3):1725-35. PubMed ID: 26729501
[TBL] [Abstract][Full Text] [Related]
8. Frequent occurrence of trimethoprim-sulfamethoxazole hetero-resistant Staphylococcus aureus isolates in different African countries.
Coelho C; de Lencastre H; Aires-de-Sousa M
Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1243-1252. PubMed ID: 28160148
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of antimicrobial susceptibility testing results for sulfamethoxazole/trimethoprim obtained from clinical equine Staphylococcus aureus isolates using different methods.
Scholtzek AD; Hanke D; Eichhorn I; Walther B; Lübke-Becker A; van Duijkeren E; Köck R; Schwarz S; Feßler AT
Vet Microbiol; 2020 Mar; 242():108600. PubMed ID: 32122605
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
El Haj C; Murillo O; Ribera A; Lloberas N; Gómez-Junyent J; Tubau F; Fontova P; Cabellos C; Ariza J
Int J Antimicrob Agents; 2018 Jun; 51(6):854-861. PubMed ID: 29374577
[TBL] [Abstract][Full Text] [Related]
11. Addition of thymidine to culture media for accurate examination of thymidine-dependent small-colony variants of methicillin-resistant Staphylococcus aureus: a pilot study.
Horiuchi K; Matsumoto T; Ota Y; Kasuga E; Negishi T; Yaguchi T; Sugano M; Honda T
J Microbiol Methods; 2015 Mar; 110():40-4. PubMed ID: 25596520
[TBL] [Abstract][Full Text] [Related]
12.
Sato T; Uno T; Kawamura M; Fujimura S
Microb Drug Resist; 2021 Sep; 27(9):1282-1289. PubMed ID: 33689487
[TBL] [Abstract][Full Text] [Related]
13. Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe.
Nurjadi D; Olalekan AO; Layer F; Shittu AO; Alabi A; Ghebremedhin B; Schaumburg F; Hofmann-Eifler J; Van Genderen PJ; Caumes E; Fleck R; Mockenhaupt FP; Herrmann M; Kern WV; Abdulla S; Grobusch MP; Kremsner PG; Wolz C; Zanger P
J Antimicrob Chemother; 2014 Sep; 69(9):2361-8. PubMed ID: 24855123
[TBL] [Abstract][Full Text] [Related]
14. Nationwide surveillance of resistance rates of Staphylococcus aureus clinical isolates from Greek hospitals, 2012-2013.
Souli M; Karaiskos I; Galani L; Maraki S; Perivolioti E; Argyropoulou A; Charissiadou A; Zachariadou L; Tsiplakou S; Papaioannou V; Tsorlini H; Katsifa H; Baka V; Pantazi P; Paschali A; Kyratsa A; Trikka-Graphakos E; Giannopoulou P; Vogiatzakis E; Moraitou H; Papadogeorgaki H; Avgerinou H; Panagea T; Pantazatou A; Petinaki E; Stamatopoulou G; Toutouza M; Karatzoglou I; Kontopoulou K; Orfanidou M; Karantani I; Fytas P; Tzanetou K; Platsouka E; Kazila P; Chli A; Statiri N; Giamarellou H
Infect Dis (Lond); 2016 Apr; 48(4):287-292. PubMed ID: 26635179
[TBL] [Abstract][Full Text] [Related]
15. Frequency of small-colony variants and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients.
Suwantarat N; Rubin M; Bryan L; Tekle T; Boyle MP; Carroll KC; Jennings MT
Diagn Microbiol Infect Dis; 2018 Apr; 90(4):296-299. PubMed ID: 29343421
[TBL] [Abstract][Full Text] [Related]
16. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients.
Vergison A; Denis O; Deplano A; Casimir G; Claeys G; DeBaets F; DeBoeck K; Douat N; Franckx H; Gigi J; Ieven M; Knoop C; Lebeque P; Lebrun F; Malfroot A; Paucquay F; Pierard D; Van Eldere J; Struelens MJ
J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activities of trimethoprim/sulfamethoxazole, 5-iodo-2'-deoxyuridine and rifampicin against Staphylococcus aureus.
Zander J; Besier S; Faetke S; Saum SH; Müller V; Wichelhaus TA
Int J Antimicrob Agents; 2010 Dec; 36(6):562-5. PubMed ID: 20947313
[TBL] [Abstract][Full Text] [Related]
18. Detection of Small Colony Variants Among Methicillin-Resistant Staphylococcus aureus Blood Isolates.
Yagci S; Sancak B; Hascelik G
Microb Drug Resist; 2016 Dec; 22(8):712-716. PubMed ID: 27058213
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.
Elwell LP; Wilson HR; Knick VB; Keith BR
Antimicrob Agents Chemother; 1986 Jun; 29(6):1092-4. PubMed ID: 3488022
[TBL] [Abstract][Full Text] [Related]
20. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
